Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Epsilen Bio logo — Epsilen Bio is developing an Epigenetic Silencing therapy to...

Epsilen Bio

Epsilen Bio is developing an Epigenetic Silencing therapy to treat human diseases and underserved medical conditions.

Founded 2019 Seed Biotechnology, Health Care +1

General Information

Company Name Epsilen Bio
Founded Year 2019
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

Get notified when Epsilen Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Epsilen Bio

Epsilen Bio is a biotechnology startup founded in 2019, with a focus on developing Epigenetic Silencing therapy for treating human diseases and underserved medical conditions. Their slogan, "Epsilen Bio is developing an Epigenetic Silencing therapy to treat human diseases and underserved medical conditions," embodies their mission. The company's innovative approach involves targeting genes implicated in pathological mechanisms using stable genomic modifications to achieve lasting therapeutic effects, paving the way for groundbreaking treatments in the future. In April 2020, Epsilen Bio secured a Seed Round investment from Sofinnova Partners, signifying growing interest and support from investors in their pioneering work. As Epsilen Bio operates within the Biotechnology and Health Care industries, it is positioned to make a significant impact within these sectors.

Taxonomy: Epigenetics, Therapeutics, Gene Therapy, Genomic Modification, Medical Research, Pathological Mechanisms, Underserved Medical Conditions, Milan, Italy, Healthcare Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
24 Apr 2020

Latest News

View All
Tune Therapeutics' epigenetic platform resonates with investors as it snags $40M in financing — Fiercebiotech.com
Tune Therapeutics' epigenetic platform resonates with investors as it snags $40M in financing
Fiercebiotech.com Dec 02, 2021

Epsilen Bio Alternatives & Competitors

Epsilen Bio vs
MTF Transport Modular Services
MTF Transport Modular Services

We deliver medical products and service from point of injury until recovery.

Epsilen Bio vs
Merlin Medtech AS
Merlin Medtech AS Norway

Saving lives with light! Land - Sea - Air

4 employees
Manufacturing, Medical Devices
Epsilen Bio vs
Viva MedSuites
Viva MedSuites

The Low-Risk Way To Have A High-End Medical Office- By the hour, part-time or full-time.

3 employees
Health Care

FAQ About Epsilen Bio

Epsilen Bio is developing an Epigenetic Silencing therapy to treat human diseases and underserved medical conditions.
Epsilen Bio was founded in 2019.
Epsilen Bio operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Epsilen Bio has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Epsilen Bio include MTF Transport Modular Services, Merlin Medtech AS, Viva MedSuites, 2 Minute Medicine®, MedExpert. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Epsilen Bio and MTF Transport Modular Services are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Epsilen Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy